# Genable Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genable-technologies

- Industry: Biotechnology
- Headquarters: Dublin, Ireland
- Website: www.genable.net
- Total disclosed funding: $8.3M
- Latest round: Series B (Nov 11, 2011)
- Investors on record: 2

## About

Genable Technologies Limited provides innovative Pay by Phone casino services, enhancing the online gambling experience by allowing seamless mobile transactions directly from users' devices.Genable Technologies Limited specializes in mobile payment solutions for online gambling, facilitating direct deposits through mobile billing systems. The company is headquartered in Dublin, Ireland. It was founded and has undergone strategic developments including a successful Series B funding round where it raised EUR 5.00 mn led by Fountain Healthcare Partners. Genable Technologies has been involved in 3 deals, with the most recent on March 7, 2016. The company was acquired by Spark Therapeutics, a subsidiary of The Children's Hospital of Philadelphia, along with other notable investors.The company specializes in providing Pay by Phone casino services, which represent a significant innovation in the online gambling sector. Their core offering allows users to make deposits directly through their mobile devices, utilizing existing mobile billing systems or prepaid balances, thus eliminating the need for traditional banking methods such as credit cards or bank accounts. This service enhances user anonymity and convenience, allowing players to seamlessly fund their gaming activities with only a few taps on their devices. The primary end users include online gamblers seeking an efficient and secure payment method, and the customer base spans various geographical markets, notably in Europe and North America, where mobile payment solutions have gained traction. By streamlining the deposit process and ensuring immediate transaction completion, the company addresses common pain points associated with traditional payment methods, such as delays and security concerns.The company generates revenue through transaction fees associated with Pay by Phone deposits made by users at partnered online casinos. The transaction structure typically operates on a direct-to-consumer model, where players utilize the Pay by Phone method to add funds to their casino accounts. Each transaction incurs a fee that is either absorbed by the casino or passed on to the user, depending on the partnership agreements in place. The company's flagship service facilitates immediate transactions, which attracts a high volume of users looking for fast and secure payment options. Additionally, the firm may engage in partnerships with various online casinos, allowing them to expand their reach and integrate their payment solutions into these platforms, ultimately enhancing their revenue stream through increased transaction volumes.Genable Technologies Limited is focused on expanding its product offerings and geographic presence. The company is currently designing new features for its Pay by Phone services, with plans for a launch in early 2024. Expansion into additional markets in Europe and North America is targeted for the same year. The recent funding of EUR 5.00 mn will be utilized to support these initiatives, enhancing product development and market penetration efforts.

## Funding rounds

- Series B, Nov 11, 2011, $6.9M — Delta Partners, Fountain Healthcare Partners
- Series A, Oct 1, 2004, $1.4M — Delta Partners

## Investors

- Delta Partners (https://capitalatlas.ai/funds/delta-partners) — Series A, Series B
- Fountain Healthcare Partners (https://capitalatlas.ai/funds/fountain-healthcare-partners) — Series B
